Group 1: Earnings Performance - RadNet reported quarterly earnings of $0.16 per share, matching the Zacks Consensus Estimate, but down from $0.24 per share a year ago [1] - The company posted revenues of $459.71 million for the quarter ended June 2024, exceeding the Zacks Consensus Estimate by 5.12% and up from $403.72 million year-over-year [2] - Over the last four quarters, RadNet has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - RadNet shares have increased approximately 71% since the beginning of the year, significantly outperforming the S&P 500's gain of 9.9% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.16 for the coming quarter and $0.58 for the current fiscal year [4][7] - The estimate revisions trend for RadNet is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Group 3: Industry Context - The Medical - Outpatient and Home Healthcare industry, to which RadNet belongs, is currently in the top 35% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact RadNet's stock performance [5]
RadNet (RDNT) Q2 Earnings Match Estimates